Back to Search
ERIC LENZE, MD
MD
Psychiatry Physician
NPI: 1619941846IndividualAccepts Medicare
Specialties, Licenses & Credentials
Geriatric Psychiatry Physician
Psychiatry & Neurology — Geriatric Psychiatry
Code: 2084P0805X
2007029603(MO)
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
2007029603(MO)
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1994
Clinical Trials (7)
7
Linked Trials
0
Recruiting
7
With Results
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
NCT02960763COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Ketamine for Older Adults Pilot
NCT04504175COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training
NCT03272711COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
NCT00183729COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
NCT00227994COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Drug Therapy for Generalized Anxiety Disorder Among the Elderly
NCT00105586COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)
NCT00892047COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Cognitive changes in older adults receiving pharmacotherapy for treatment-resistant depression: a secondary analysis of the OPTIMUM randomised controlled trial.
PMID 41237789·Lancet Healthy Longev·2025
2-rct
Alcohol and substance use in older adults with treatment-resistant depression.
PMID 38822571·Int J Geriatr Psychiatry·2024
2-rct
Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression.
PMID 37392089·Int J Geriatr Psychiatry·2023
3-trial
Age or age of onset: which is the best criterion to classify late-life depression?
PMID 36961017·Int Clin Psychopharmacol·2023
8-other
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.
PMID 36867173·N Engl J Med·2023
4-observational
Association between lean muscle mass and treatment-resistant late-life depression in the IRL-GRey randomized controlled trial.
PMID 36594430·Int Psychogeriatr·2023
2-rct
Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome.
PMID 35771573·JAMA Netw Open·2022
3-trial
Coprescribed Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depressive Disorders: Association With Treatment Outcomes.
PMID 32991792·J Clin Psychiatry·2020
3-trial
Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial.
PMID 32212856·Am J Psychiatry·2020
2-rct
Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
PMID 31846575·J Clin Psychiatry·2019
4-observational
Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.
PMID 30358242·J Clin Psychiatry·2018
3-trial
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
PMID 29924506·J Clin Psychiatry·2018
2-rct
Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
PMID 28068779·Am J Psychiatry·2017
4-observational
Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorder.
PMID 27645461·Int J Geriatr Psychiatry·2017
8-other
Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study.
PMID 27282141·Int J Geriatr Psychiatry·2017
8-other
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
PMID 26963689·JAMA Psychiatry·2016
4-observational
Trajectories of suicidal ideation in depressed older adults undergoing antidepressant treatment.
PMID 26708830·J Psychiatr Res·2016
8-other
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
PMID 26423182·Lancet·2015
4-observational
Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
PMID 26278231·Psychiatr Serv·2015
4-observational
Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
PMID 26288246·JAMA Psychiatry·2015
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 S TAYLOR AVE, DEPT PSYCHIATRY, STE 122
SAINT LOUIS, MO 63110 - Phone
- (314) 286-1700
Quick Facts
- NPI
- 1619941846
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 32
- Clinical Trials
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile